87 related articles for article (PubMed ID: 22394012)
1. Tissue microarray and digital image analysis: a methodological study with special reference to the microenvironment in Hodgkin lymphoma.
Glimelius I; Qvarnström F; Simonsson M; Ekwall A; Smedby KE; Molin D; Amini RM
Histopathology; 2012 Jul; 61(1):26-32. PubMed ID: 22394012
[TBL] [Abstract][Full Text] [Related]
2. Immunological environment in colorectal cancer: a computer-aided morphometric study of whole slide digital images derived from tissue microarray.
Eyraud D; Granger B; Bardier A; Loncar Y; Gottrand G; Le Naour G; Siksik JM; Vaillant JC; Klatzmann D; Puybasset L; Charlotte F; Augustin J
Pathology; 2018 Oct; 50(6):607-612. PubMed ID: 30166125
[TBL] [Abstract][Full Text] [Related]
3. Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.
Cunha KS; Caruso AC; Gonçalves AS; Bernardo VG; Pires AR; da Fonseca EC; de Faria PA; da Silva LE; Geller M; de Moura-Neto RS; Lopes VS
J Clin Pathol; 2009 Jul; 62(7):629-33. PubMed ID: 19318344
[TBL] [Abstract][Full Text] [Related]
4. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
Muenst S; Hoeller S; Dirnhofer S; Tzankov A
Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
[TBL] [Abstract][Full Text] [Related]
5. Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.
Rajnai H; Bödör C; Balogh Z; Gagyi E; Csomor J; Krenács T; Tóth E; Matolcsy A
Histopathology; 2012 May; 60(6B):E66-75. PubMed ID: 22394030
[TBL] [Abstract][Full Text] [Related]
6. Tissue microarray technology in the routine assessment of HER-2 status in invasive breast cancer: a prospective study of the use of immunohistochemistry and fluorescence in situ hybridization.
Graham AD; Faratian D; Rae F; Thomas JS
Histopathology; 2008 Jun; 52(7):847-55. PubMed ID: 18494613
[TBL] [Abstract][Full Text] [Related]
7. Tissue microarray technique in evaluation of proliferative activity in invasive ductal breast cancer.
Kobierzycki C; Pula B; Wojnar A; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2012 Mar; 32(3):773-7. PubMed ID: 22399591
[TBL] [Abstract][Full Text] [Related]
8. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
9. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma.
Tzankov A; Matter MS; Dirnhofer S
Pathobiology; 2010; 77(6):301-8. PubMed ID: 21266828
[TBL] [Abstract][Full Text] [Related]
10. The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
Kelley TW; Pohlman B; Elson P; Hsi ED
Am J Clin Pathol; 2007 Dec; 128(6):958-65. PubMed ID: 18024321
[TBL] [Abstract][Full Text] [Related]
11. Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience.
Faratian D; Kay C; Robson T; Campbell FM; Grant M; Rea D; Bartlett JM
Histopathology; 2009 Nov; 55(5):587-93. PubMed ID: 19912364
[TBL] [Abstract][Full Text] [Related]
12. Validation of tissue microarray technology in endometrioid cancer of the endometrium.
Fons G; Hasibuan SM; van der Velden J; ten Kate FJ
J Clin Pathol; 2007 May; 60(5):500-3. PubMed ID: 16822874
[TBL] [Abstract][Full Text] [Related]
13. The role of the microenvironment in human immunodeficiency virus-associated classical Hodgkin lymphoma.
Koulis A; Trivedi P; Ibrahim H; Bower M; Naresh KN
Histopathology; 2014 Dec; 65(6):749-56. PubMed ID: 24809535
[TBL] [Abstract][Full Text] [Related]
14. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
15. Digital pathology for the validation of tissue microarrays in peripheral T-cell lymphomas.
Pedersen MB; Riber-Hansen R; Nielsen PS; Bendix K; Hamilton-Dutoit SJ; D'Amore F; Steiniche T
Appl Immunohistochem Mol Morphol; 2014 Sep; 22(8):577-84. PubMed ID: 24897068
[TBL] [Abstract][Full Text] [Related]
16. Use and validation of epithelial recognition and fields of view algorithms on virtual slides to guide TMA construction.
Barsky S; Gentchev L; Basu A; Jimenez R; Boussaid K; Gholap A
Biotechniques; 2009 Nov; 47(5):927-38. PubMed ID: 20041846
[TBL] [Abstract][Full Text] [Related]
17. A new approach to the validation of tissue microarrays.
Goethals L; Perneel C; Debucquoy A; De Schutter H; Borghys D; Ectors N; Geboes K; McBride WH; Haustermans KM
J Pathol; 2006 Apr; 208(5):607-14. PubMed ID: 16435284
[TBL] [Abstract][Full Text] [Related]
18. Digital microscopy for boosting database integration and analysis in TMA studies.
Krenacs T; Ficsor L; Varga SV; Angeli V; Molnar B
Methods Mol Biol; 2010; 664():163-75. PubMed ID: 20690062
[TBL] [Abstract][Full Text] [Related]
19. Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
J Clin Pathol; 2007 Apr; 60(4):397-404. PubMed ID: 16775123
[TBL] [Abstract][Full Text] [Related]
20. Tumor and inflammation markers in melanoma using tissue microarrays: a validation study.
Jensen TO; Riber-Hansen R; Schmidt H; Hamilton-Dutoit SJ; Steiniche T
Melanoma Res; 2011 Dec; 21(6):509-15. PubMed ID: 21946018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
